首页> 美国卫生研究院文献>Molecules >Recent Advances in Encapsulation Protection and Oral Delivery of Bioactive Proteins and Peptides using Colloidal Systems
【2h】

Recent Advances in Encapsulation Protection and Oral Delivery of Bioactive Proteins and Peptides using Colloidal Systems

机译:使用胶体系统封装保护和口服生物活性蛋白和肽的最新进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There are many areas in medicine and industry where it would be advantageous to orally deliver bioactive proteins and peptides (BPPs), including ACE inhibitors, antimicrobials, antioxidants, hormones, enzymes, and vaccines. A major challenge in this area is that many BPPs degrade during storage of the product or during passage through the human gut, thereby losing their activity. Moreover, many BPPs have undesirable taste profiles (such as bitterness or astringency), which makes them unpleasant to consume. These challenges can often be overcome by encapsulating them within colloidal particles that protect them from any adverse conditions in their environment, but then release them at the desired site-of-action, which may be inside the gut or body. This article begins with a discussion of BPP characteristics and the hurdles involved in their delivery. It then highlights the characteristics of colloidal particles that can be manipulated to create effective BPP-delivery systems, including particle composition, size, and interfacial properties. The factors impacting the functional performance of colloidal delivery systems are then highlighted, including their loading capacity, encapsulation efficiency, protective properties, retention/release properties, and stability. Different kinds of colloidal delivery systems suitable for encapsulation of BPPs are then reviewed, such as microemulsions, emulsions, solid lipid particles, liposomes, and microgels. Finally, some examples of the use of colloidal delivery systems for delivery of specific BPPs are given, including hormones, enzymes, vaccines, antimicrobials, and ACE inhibitors. An emphasis is on the development of food-grade colloidal delivery systems, which could be used in functional or medical food applications. The knowledge presented should facilitate the design of more effective vehicles for the oral delivery of bioactive proteins and peptides.
机译:在医学和工业中,有许多领域可以口服生物活性蛋白和肽(BPP),包括ACE抑制剂,抗微生物剂,抗氧化剂,激素,酶和疫苗,这将是有利的。该领域的主要挑战是许多BPP在产品存储过程中或通过人体肠道过程中会降解,从而丧失其活性。此外,许多BPP具有不良的味道(例如苦味或涩味),这使它们不宜食用。这些挑战通常可以通过将它们封装在胶体颗粒中来解决,以保护它们免受环境中的任何不利条件的影响,然后在所需的作用部位(可能在肠道或体内)释放它们。本文首先讨论BPP的特性以及交付过程中涉及的障碍。然后,它突出了可以操纵以创建有效的BPP输送系统的胶体颗粒的特性,包括颗粒组成,尺寸和界面特性。然后重点介绍了影响胶体递送系统功能性能的因素,包括它们的负载能力,封装效率,保护性,保留/释放性和稳定性。然后回顾了适用于BPP封装的各种胶体递送系统,例如微乳剂,乳剂,固体脂质颗粒,脂质体和微凝胶。最后,给出了使用胶体递送系统递送特定BPP的一些例子,包括激素,酶,疫苗,抗微生物剂和ACE抑制剂。重点是开发食品级胶体递送系统,该系统可用于功能性或医疗食品应用中。提出的知识应有助于设计更有效的载体,用于口服递送生物活性蛋白和肽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号